ArticleBMC cancer2024

Osteosarcoma cells depend on MCL-1 for survival, and osteosarcoma metastases respond to MCL-1 antagonism plus regorafenib in vivo.

Yanhao Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.